Profil

de Marneffe Nils

Département des sciences cliniques

See author's contact details
Main Referenced Co-authors
Lancellotti, Patrizio  (8)
Dulgheru, Raluca Elena  (3)
Petitjean, Hélène  (3)
Damas, François  (2)
Hanoul, Chloé  (2)
Main Referenced Keywords
Humans (5); Hypertrophic cardiomyopathy (2); Mavacamten (2); Recommendations (2); Treatment (2);
Main Referenced Disciplines
Cardiovascular & respiratory systems (8)

Publications (total 8)

The most downloaded
562 downloads
DE MARNEFFE, N., Dulgheru, R. E., Ancion, A., Moonen, M., & Lancellotti, P. (2022). Cardiac amyloidosis: a review of the literature. Acta Cardiologica, 1-10. doi:10.1080/00015385.2021.1992990 https://hdl.handle.net/2268/293902

The most cited

9 citations (Scopus®)

Ilardi, F., Postolache, A., Dulgheru, R., Trung, M.-L. N., DE MARNEFFE, N., Sugimoto, T., Go, Y. Y., Oury, C., Esposito, G., & LANCELLOTTI, P. (11 March 2022). Prognostic Value of Non-Invasive Global Myocardial Work in Asymptomatic Aortic Stenosis. Journal of Clinical Medicine, 11 (6). doi:10.3390/jcm11061555 https://hdl.handle.net/2268/292595

Lancellotti, P., de Marneffe, N., & Scheen, A. (February 2024). Le médicament du moisMavacamten (Camzyos®) : premier inhibiteur réversible de l’ATP-ase de la myosine pour le traitement des cardiomyopathies hypertrophiques obstructives. Revue Médicale de Liège, 79 (2), 120-128.
Editorial Reviewed verified by ORBi

PETITJEAN, H., de Marneffe, N., Nguyen Trung, M.-L., Hanoul, C., Rorive, A., Moonen, M., & Lancellotti, P. (December 2023). Cardio-oncologie et cardio-obstétrique : importance d’une approche multidisciplinaire. Revue Médicale de Liège, 78 (12), 695-702.
Editorial Reviewed verified by ORBi

Hanoul, C., de Marneffe, N., Dulgheru, R. E., DAMAS, F., Tajildin, R., PETITJEAN, H., & Lancellotti, P. (December 2023). Sténose aortique : nouveautés thérapeutiques et diagnostiques. Revue Médicale de Liège, 78 (12), 689-694.
Editorial Reviewed verified by ORBi

Lancellotti, P., MASSON, A., DAMAS, F., & de Marneffe, N. (November 2023). Nouvelles recommandations pour le diagnostic et la prise en charge thérapeutique de la cardiomyopathie hypertrophique. Revue Médicale de Liège, 78 (11), 619-625.
Editorial Reviewed verified by ORBi

Lancellotti, P., PETITJEAN, H., de Marneffe, N., & Cosyns, B. (November 2022). Focus issue on cardiomyopathies. Acta Cardiologica, 77 (9), 765-767. doi:10.1080/00015385.2022.2158618
Editorial reviewed

DE MARNEFFE, N., Dulgheru, R. E., Ancion, A., Moonen, M., & Lancellotti, P. (2022). Cardiac amyloidosis: a review of the literature. Acta Cardiologica, 1-10. doi:10.1080/00015385.2021.1992990
Peer Reviewed verified by ORBi

Ilardi, F., Postolache, A., Dulgheru, R., Trung, M.-L. N., DE MARNEFFE, N., Sugimoto, T., Go, Y. Y., Oury, C., Esposito, G., & LANCELLOTTI, P. (11 March 2022). Prognostic Value of Non-Invasive Global Myocardial Work in Asymptomatic Aortic Stenosis. Journal of Clinical Medicine, 11 (6). doi:10.3390/jcm11061555
Peer Reviewed verified by ORBi

Dulgheru, R. E., DE MARNEFFE, N., & Lancellotti, P. (December 2021). Amylose cardiaque à transthyrétine de type sénile et sténose aortique - ne manquez pas le diagnostic ! Journal de Cardiologie, 12, 24-27.
Peer reviewed

Contact ORBi